Whether increased adipose tissue fibrosis in young patients with SRC-1 variants predisposes them to the early development of metabolic complications such as type 2 diabetes and fatty liver disease is an important question that needs to be addressed in larger longitudinal studies. The gene discussed is NCOA1; the disease is type 2 diabetes mellitus.